Embree Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Embree Financial Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,294	Closed	-$273K	–	246
2025 Q2	$273K	Sell	3,294 -1,020	-24%	-$81.4K	0.04%	185
2025 Q1	$350K	Buy	4,314 +815	+23%	+$72.8K	0.06%	151
2024 Q4	$315K	Sell	3,499 -401	-10%	-$38.9K	0.05%	155
2024 Q3	$385K	Buy	3,900 +701	+22%	+$68.9K	0.07%	135
2024 Q2	$297K	Buy	+3,199	New	+$287K	0.06%	149

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Embree Financial Group's XBI Position: Q3 2025 in Review

Embree Financial Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 3,294 shares — an estimated $273K sold.

Embree Financial Group first reported a position in XBI in Q2 2024 and held it in 5 quarters. The position peaked at $385K in Q3 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Embree Financial Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Embree Financial Group sold 3,294 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $273K.
Embree Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 5 quarters.
Embree Financial Group's State Street SPDR S&P Biotech ETF position peaked at $385K in Q3 2024.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Embree Financial Group's 13F filing for Q3 2025, filed 9 Oct 2025.